Deconsolidation in Medical Devices
The medical device/diagnostic industry has been a hotbed of merger and acquisition activity over the past five years, mostly driven by large companies. But by at least one measure, the industry is actually deconsolidating, according to data developed by The Wilkerson Group/IBM.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."